Symbols / ARCT $8.62 -2.27% Arcturus Therapeutics Holdings Inc.

Healthcare • Biotechnology • United States • NGM
ARCT Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 clinical development; and ARCT-810 (LUNAR-OTC), which is in Phase 2 clinical development to address ornithine transcarbamylase (OTC) deficiency. In addition, it develops KOSTAIVE, a self-amplifying RNA vaccine for COVID-19; ARCT-2138 (LUNAR-FLU), which is in Phase1 clinical trial for the treatment of seasonal influenza; and ARCT-2304 (LUNAR-H5N1) that is in Phase1 clinical trial for the treatment of Pandemic Influenza. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.

Fundamentals
Scroll to Statements
Market Cap 245.01M Enterprise Value 39.10M Income -65.78M Sales 82.03M Book/sh 7.53 Cash/sh 8.12
Dividend Yield — Payout 0.00% Employees 106 IPO — P/E — Forward P/E -2.05
PEG — P/S 2.99 P/B 1.14 P/C — EV/EBITDA -0.53 EV/Sales 0.48
Quick Ratio 6.50 Current Ratio 6.64 Debt/Eq 11.68 LT Debt/Eq — EPS (ttm) -2.40 EPS next Y -4.21
EPS Growth — Revenue Growth -68.40% Earnings 2026-05-11 ROA -15.50% ROE -28.92% ROIC —
Gross Margin -36.79% Oper. Margin -4.35% Profit Margin -80.19% Shs Outstand 28.42M Shs Float 26.28M Short Float 34.25%
Short Ratio 11.23 Short Interest — 52W High 24.17 52W Low 5.85 Beta 2.44 Avg Volume 472.19K
Volume 322.52K Target Price $23.30 Recom Buy Prev Close $8.82 Price $8.62 Change -2.27%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$23.30
Mean price target
2. Current target
$8.62
Latest analyst target
3. DCF / Fair value
$5.81
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$8.62
Low
$8.00
High
$68.00
Mean
$23.30

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-18 init B. Riley Securities Neutral → Buy $22
2026-03-05 main Citigroup Buy → Buy $21
2026-03-04 main Citigroup Neutral → Neutral $8
2026-03-04 main Piper Sandler Overweight → Overweight $25
2026-01-06 main Citigroup Neutral → Neutral $7
2025-11-13 main Citigroup Neutral → Neutral $9
2025-11-11 main Piper Sandler Overweight → Overweight $72
2025-11-11 main HC Wainwright & Co. Neutral → Neutral $9
2025-10-24 down HC Wainwright & Co. Buy → Neutral $12
2025-10-23 down Citigroup Buy → Neutral $12
2025-10-23 main Wells Fargo Overweight → Overweight $20
2025-10-23 down Guggenheim Buy → Neutral —
2025-10-22 main BTIG Buy → Buy $23
2025-10-22 down Guggenheim Buy → Neutral —
2025-08-22 main Leerink Partners Outperform → Outperform $54
2025-08-12 main Wells Fargo Overweight → Overweight $42
2025-08-12 main Citigroup Buy → Buy $49
2025-07-02 main Scotiabank Sector Outperform → Sector Outperform $35
2025-05-28 init Scotiabank — → Sector Outperform $32
2025-05-14 main Wells Fargo Overweight → Overweight $45
News
RSS: Latest ARCT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-08-15 SASSINE ANDY H Chief Financial Officer — 1,238 $16.56 $20,499
2024-10-15 CHIVUKULA PADMANABH Chief Operating Officer — 12,000 $20.76 $249,121
2024-06-14 FARRELL PETER CRAIG Director — 3,131 — —
2024-06-14 MARKELS JOHN Director — 3,131 — —
2024-06-14 BARLOW JAMES F. Director — 3,131 — —
2024-06-14 HOLMES EDWARD W. Director — 3,131 — —
2024-06-14 MARQUET MAGDA Director — 3,131 — —
2024-06-14 MARANTZ JING L. Director — 3,131 — —
2024-06-12 SASSINE ANDY H Chief Financial Officer — 50,000 $32.03 $1,601,500
2024-06-05 CHIVUKULA PADMANABH Chief Operating Officer — 114 $45.00 $5,130
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
67.22
-51.43%
138.39
-12.27%
157.75
-23.33%
205.75
Operating Revenue
67.22
-51.43%
138.39
-12.27%
157.75
-23.33%
205.75
Operating Expense
143.48
-38.70%
234.06
-0.80%
235.95
+21.89%
193.58
Research And Development
112.21
-42.50%
195.16
+1.57%
192.13
+30.04%
147.75
Selling General And Administration
46.08
-12.77%
52.82
-0.09%
52.87
+14.76%
46.07
General And Administrative Expense
46.08
-12.77%
52.82
-0.09%
52.87
+14.76%
46.07
Other Gand A
46.08
-12.77%
52.82
-0.09%
52.87
+14.76%
46.07
Other Operating Expenses
-14.81
-6.39%
-13.92
-53.81%
-9.05
-3609.43%
-0.24
Total Expenses
143.48
-38.70%
234.06
-0.80%
235.95
+21.89%
193.58
Operating Income
-76.26
+20.29%
-95.67
-22.33%
-78.20
-742.24%
12.18
Total Operating Income As Reported
-76.26
+20.29%
-95.67
-22.33%
-78.20
-742.24%
12.18
EBITDA
-62.75
+18.93%
-77.40
-220.30%
-24.16
-276.34%
13.70
Normalized EBITDA
-63.13
+17.94%
-76.93
-32.89%
-57.89
-504.76%
14.30
Reconciled Depreciation
3.02
-14.64%
3.54
+19.85%
2.96
+93.65%
1.53
EBIT
-65.77
+18.74%
-80.94
-198.45%
-27.12
-322.73%
12.18
Total Unusual Items
0.38
+181.10%
-0.47
-101.40%
33.72
+5739.46%
-0.60
Total Unusual Items Excluding Goodwill
0.38
+181.10%
-0.47
-101.40%
33.72
+5739.46%
-0.60
Special Income Charges
0.00
0.00
-100.00%
33.95
0.00
Other Special Charges
—
—
-33.95
—
Net Income
-65.78
+18.73%
-80.94
-172.30%
-29.73
-417.95%
9.35
Pretax Income
-65.78
+18.73%
-80.94
-190.23%
-27.89
-362.03%
10.64
Net Non Operating Interest Income Expense
10.10
-33.56%
15.20
-8.41%
16.59
+4050.24%
-0.42
Interest Expense Non Operating
0.01
0.00
-100.00%
0.77
-74.41%
3.00
Net Interest Income
10.10
-33.56%
15.20
-8.41%
16.59
+4050.24%
-0.42
Interest Expense
0.01
0.00
-100.00%
0.77
-74.41%
3.00
Interest Income Non Operating
10.10
-33.50%
15.20
-12.47%
17.36
+572.57%
2.58
Interest Income
10.10
-33.50%
15.20
-12.47%
17.36
+572.57%
2.58
Other Income Expense
0.38
+181.10%
-0.47
-101.40%
33.72
+3130.01%
-1.11
Gain On Sale Of Security
0.38
+181.10%
-0.47
-105.68%
-0.23
+61.71%
-0.60
Tax Provision
0.00
+100.00%
-0.00
-100.22%
1.83
+41.70%
1.29
Tax Rate For Calcs
0.00
0.00
-100.00%
0.00
+72.61%
0.00
Tax Effect Of Unusual Items
0.00
0.00
-100.00%
7.08
+9834.02%
-0.07
Net Income Including Noncontrolling Interests
-65.78
+18.73%
-80.94
-172.30%
-29.73
-417.95%
9.35
Net Income From Continuing Operation Net Minority Interest
-65.78
+18.73%
-80.94
-172.30%
-29.73
-417.95%
9.35
Net Income From Continuing And Discontinued Operation
-65.78
+18.73%
-80.94
-172.30%
-29.73
-417.95%
9.35
Net Income Continuous Operations
-65.78
+18.73%
-80.94
-172.30%
-29.73
-417.95%
9.35
Normalized Income
-66.17
+17.78%
-80.47
-42.76%
-56.37
-670.85%
9.87
Net Income Common Stockholders
-65.78
+18.73%
-80.94
-172.30%
-29.73
-417.95%
9.35
Diluted EPS
-2.40
+20.00%
-3.00
-200.00%
-1.00
-385.71%
0.35
Basic EPS
-2.40
+20.00%
-3.00
-200.00%
-1.00
-385.71%
0.35
Basic Average Shares
27.39
+1.43%
27.00
+1.40%
26.63
+0.69%
26.45
Diluted Average Shares
27.39
+1.43%
27.00
+1.40%
26.63
-1.72%
27.09
Diluted NI Availto Com Stockholders
-65.78
+18.73%
-80.94
-172.30%
-29.73
-417.95%
9.35
Earnings From Equity Interest
—
0.00
0.00
+100.00%
-0.52
Total Other Finance Cost
—
—
0.00
-99.76%
0.42
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
271.15
-21.19%
344.07
-19.87%
429.40
-4.66%
450.39
Current Assets
241.45
-21.09%
305.98
-20.85%
386.59
-4.15%
403.33
Cash Cash Equivalents And Short Term Investments
230.91
-2.58%
237.03
-18.83%
292.00
-25.49%
391.88
Cash And Cash Equivalents
230.91
-2.58%
237.03
-18.83%
292.00
-25.49%
391.88
Receivables
5.56
+40.01%
3.97
-87.61%
32.06
+1060.06%
2.76
Accounts Receivable
5.56
+40.01%
3.97
-87.61%
32.06
+1060.06%
2.76
Prepaid Assets
—
—
—
—
Restricted Cash
0.00
-100.00%
55.00
+0.00%
55.00
0.00
Other Current Assets
4.97
-50.16%
9.98
+32.66%
7.52
-13.41%
8.69
Total Non Current Assets
29.70
-22.02%
38.09
-11.03%
42.81
-9.02%
47.05
Net PPE
27.82
-23.17%
36.20
-11.54%
40.93
-8.97%
44.96
Gross PPE
40.31
-16.05%
48.02
-3.32%
49.67
-2.12%
50.74
Accumulated Depreciation
-12.49
-5.76%
-11.81
-35.14%
-8.74
-51.13%
-5.78
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.67
-8.78%
1.83
-17.87%
2.23
+5.73%
2.11
Construction In Progress
—
0.00
-100.00%
0.23
-93.03%
3.34
Other Properties
36.02
-17.26%
43.54
-2.26%
44.55
+4.09%
42.80
Leases
2.61
-1.21%
2.64
-0.41%
2.65
+6.58%
2.49
Investments And Advances
—
—
—
0.00
Long Term Equity Investment
—
—
—
0.00
Other Non Current Assets
1.89
+0.00%
1.89
+0.00%
1.89
-9.98%
2.09
Total Liabilities Net Minority Interest
57.16
-44.55%
103.09
-31.68%
150.89
-16.21%
180.07
Current Liabilities
36.38
-44.45%
65.49
-20.12%
81.99
-35.43%
126.98
Payables And Accrued Expenses
16.97
-36.43%
26.70
+9.33%
24.42
+9.55%
22.29
Payables
4.24
-41.13%
7.19
+21.52%
5.92
-32.30%
8.74
Accounts Payable
4.24
-41.13%
7.19
+36.28%
5.28
-29.13%
7.45
Current Accrued Expenses
12.74
-34.70%
19.50
+5.43%
18.50
+36.55%
13.55
Pensionand Other Post Retirement Benefit Plans Current
6.95
-47.78%
13.30
+124.82%
5.92
+46.56%
4.04
Total Tax Payable
—
0.00
-100.00%
0.64
-50.50%
1.29
Income Tax Payable
—
0.00
-100.00%
0.64
-50.50%
1.29
Current Debt And Capital Lease Obligation
4.21
+18.64%
3.55
-17.57%
4.31
-93.32%
64.54
Current Debt
—
—
—
60.66
Other Current Borrowings
—
—
—
60.66
Current Capital Lease Obligation
4.21
+18.64%
3.55
-17.57%
4.31
+10.94%
3.88
Current Deferred Liabilities
8.25
-62.41%
21.93
-53.67%
47.34
+31.09%
36.12
Current Deferred Revenue
8.25
-62.41%
21.93
-53.67%
47.34
+31.09%
36.12
Total Non Current Liabilities Net Minority Interest
20.78
-44.73%
37.60
-45.43%
68.90
+29.78%
53.09
Long Term Debt And Capital Lease Obligation
20.78
-16.86%
25.00
-3.51%
25.91
-14.26%
30.22
Long Term Debt
—
—
—
—
Long Term Capital Lease Obligation
20.78
-16.86%
25.00
-3.51%
25.91
-14.26%
30.22
Non Current Deferred Liabilities
0.00
-100.00%
12.60
-70.34%
42.50
+111.73%
20.07
Non Current Deferred Revenue
0.00
-100.00%
12.60
-70.34%
42.50
+111.73%
20.07
Other Non Current Liabilities
—
—
0.50
-82.28%
2.80
Stockholders Equity
213.99
-11.20%
240.98
-13.48%
278.51
+3.03%
270.31
Common Stock Equity
213.99
-11.20%
240.98
-13.48%
278.51
+3.03%
270.31
Capital Stock
0.03
+3.70%
0.03
+0.00%
0.03
+0.00%
0.03
Common Stock
0.03
+3.70%
0.03
+0.00%
0.03
+0.00%
0.03
Share Issued
28.41
+5.24%
27.00
+0.64%
26.83
+1.03%
26.55
Ordinary Shares Number
28.41
+5.24%
27.00
+0.64%
26.83
+1.03%
26.55
Additional Paid In Capital
728.55
+5.62%
689.76
+6.72%
646.35
+6.23%
608.43
Retained Earnings
-514.59
-14.66%
-448.81
-22.00%
-367.87
-8.79%
-338.14
Total Equity Gross Minority Interest
213.99
-11.20%
240.98
-13.48%
278.51
+3.03%
270.31
Total Capitalization
213.99
-11.20%
240.98
-13.48%
278.51
+3.03%
270.31
Working Capital
205.07
-14.73%
240.49
-21.05%
304.60
+10.22%
276.35
Invested Capital
213.99
-11.20%
240.98
-13.48%
278.51
-15.85%
330.97
Total Debt
25.00
-12.44%
28.55
-5.51%
30.22
-68.11%
94.75
Capital Lease Obligations
25.00
-12.44%
28.55
-5.51%
30.22
-11.39%
34.10
Net Tangible Assets
213.99
-11.20%
240.98
-13.48%
278.51
+3.03%
270.31
Tangible Book Value
213.99
-11.20%
240.98
-13.48%
278.51
+3.03%
270.31
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-74.27
-24.31%
-59.75
-230.11%
-18.10
-156.57%
31.99
Cash Flow From Continuing Operating Activities
-74.27
-24.31%
-59.75
-230.11%
-18.10
-156.57%
31.99
Net Income From Continuing Operations
-65.78
+18.73%
-80.94
-172.30%
-29.73
-417.95%
9.35
Depreciation Amortization Depletion
3.02
-14.64%
3.54
+19.85%
2.96
+93.65%
1.53
Depreciation
—
—
—
1.53
Depreciation And Amortization
3.02
-14.64%
3.54
+19.85%
2.96
+93.65%
1.53
Other Non Cash Items
—
—
0.50
-76.90%
2.17
Stock Based Compensation
25.41
-33.12%
37.99
+9.64%
34.65
+13.19%
30.61
Asset Impairment Charge
1.90
0.00
0.00
—
Operating Gains Losses
0.38
-18.90%
0.47
+101.39%
-33.86
-3904.83%
0.89
Net Foreign Currency Exchange Gain Loss
0.38
-18.90%
0.47
+423.33%
0.09
-76.00%
0.38
Change In Working Capital
-39.20
-88.38%
-20.81
-381.93%
7.38
+158.78%
-12.56
Change In Receivables
-1.59
-105.66%
28.09
+195.87%
-29.30
-4959.04%
0.60
Changes In Account Receivables
-1.59
-105.66%
28.09
+195.87%
-29.30
-4959.04%
0.60
Change In Prepaid Assets
5.00
+303.75%
-2.46
-310.82%
1.17
+132.51%
-3.58
Change In Payables And Accrued Expense
-18.22
-332.24%
7.85
+377.67%
-2.83
-144.64%
6.33
Change In Accrued Expense
-15.27
-357.33%
5.93
+1108.84%
-0.59
-106.23%
9.44
Change In Payable
-2.96
-254.52%
1.92
+185.57%
-2.24
+28.08%
-3.11
Change In Account Payable
-2.96
-254.52%
1.92
+185.57%
-2.24
+28.08%
-3.11
Change In Other Working Capital
-23.87
+56.76%
-55.21
-243.00%
38.61
+362.73%
-14.69
Change In Other Current Assets
3.70
-18.98%
4.56
+12.78%
4.04
+23.93%
3.26
Change In Other Current Liabilities
-4.21
-15.61%
-3.65
+15.41%
-4.31
+3.75%
-4.48
Investing Cash Flow
-0.23
+64.51%
-0.65
+77.66%
-2.90
+62.45%
-7.73
Cash Flow From Continuing Investing Activities
-0.23
+64.51%
-0.65
+77.66%
-2.90
+62.45%
-7.73
Net PPE Purchase And Sale
-0.23
+64.51%
-0.65
+77.66%
-2.90
+62.45%
-7.73
Purchase Of PPE
-0.23
+64.51%
-0.65
+77.66%
-2.90
+62.45%
-7.73
Capital Expenditure
-0.23
+64.51%
-0.65
+77.66%
-2.90
+62.45%
-7.73
Financing Cash Flow
13.38
+146.99%
5.42
+122.49%
-24.09
-742.50%
-2.86
Cash Flow From Continuing Financing Activities
13.38
+146.99%
5.42
+122.49%
-24.09
-742.50%
-2.86
Net Issuance Payments Of Debt
0.00
0.00
+100.00%
-27.36
-447.28%
-5.00
Issuance Of Debt
15.00
0.00
-100.00%
20.00
0.00
Repayment Of Debt
-15.00
0.00
+100.00%
-47.36
-847.28%
-5.00
Long Term Debt Issuance
15.00
0.00
-100.00%
20.00
0.00
Long Term Debt Payments
-15.00
0.00
+100.00%
-47.36
-847.28%
-5.00
Net Long Term Debt Issuance
0.00
0.00
+100.00%
-27.36
-447.28%
-5.00
Net Common Stock Issuance
12.27
+1699.56%
0.68
+11.99%
0.61
+48.18%
0.41
Proceeds From Stock Option Exercised
1.11
-76.58%
4.74
+77.51%
2.67
+54.22%
1.73
Changes In Cash
-61.12
-11.17%
-54.98
-21.94%
-45.09
-310.61%
21.41
Beginning Cash Position
293.91
-15.76%
348.89
-11.44%
393.98
+5.75%
372.57
End Cash Position
232.79
-20.79%
293.91
-15.76%
348.89
-11.44%
393.98
Free Cash Flow
-74.50
-23.36%
-60.40
-187.60%
-21.00
-186.54%
24.27
Interest Paid Supplemental Data
0.00
0.00
-100.00%
2.13
+161.62%
0.81
Income Tax Paid Supplemental Data
0.00
-100.00%
1.41
0.00
0.00
Common Stock Issuance
12.27
+1699.56%
0.68
+11.99%
0.61
+48.18%
0.41
Earnings Losses From Equity Investments
—
0.00
0.00
-100.00%
0.52
Issuance Of Capital Stock
12.27
+1699.56%
0.68
+11.99%
0.61
+48.18%
0.41
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category